Triad biopharmaceutical company seeks to raise $6 million
March 19, 2019 at 12:56 PM EDT
A rollercoaster year in 2018 saw the company's stock fall dramatically, but successful testing of potential drugs late in the year helped the stock price recover handily heading into a so far more stable 2019.
